Patent ID: 11918639
Assignee: JANSSEN VACCINES & PREVENTION B.V.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A  C

Claim 0:
1. A vaccine combination comprising
(i) a first composition comprising an immunologically effective amount of an adenovirus vector comprising a nucleic acid encoding an antigenic protein having SEQ ID NO:1, together with a pharmaceutically acceptable carrier; and
(ii) a second composition comprising an immunologically effective amount of an MVA vector comprising a nucleic acid encoding antigenic proteins from four filovirus subtypes having SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:4, and SEQ ID NO:5, together with a pharmaceutically acceptable carrier;, wherein the first composition is a priming composition and the second composition is a boosting composition.